Memorial Sloan Kettering Cancer Center
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Breast MRI Spectroscopy, Department of Defense (DOD)
Completed
- Conditions
- Breast Lesion
- First Posted Date
- 2007-12-28
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 146
- Registration Number
- NCT00582569
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9
Not Applicable
Terminated
- Conditions
- SarcomaNeuroblastomaCNS Cancer
- Interventions
- Drug: 131I-8H9Drug: 8H9
- First Posted Date
- 2007-12-28
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT00582608
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients
Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- Behavioral: questionnaires
- First Posted Date
- 2007-12-28
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 650
- Registration Number
- NCT00582478
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Penile Injection Anxiety
Active, not recruiting
- Conditions
- Erectile DysfunctionRadical Pelvic SurgeryPenile Injection Therapy
- Interventions
- Other: Questionnaires.
- First Posted Date
- 2007-12-28
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 126
- Registration Number
- NCT00582231
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Not Applicable
Active, not recruiting
- Conditions
- Colon CancerOvarian CancerBreast CancerBladder CancerKidney CancerProstate CancerLung Cancer
- Interventions
- Genetic: PCR/PCR/LDR Strategy
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 21081
- Registration Number
- NCT00579514
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Assessing Depression in a Geriatric Cancer Population
Active, not recruiting
- Conditions
- Breast CancerProstate Cancer
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 201
- Registration Number
- NCT00580476
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors
Completed
- Conditions
- Primary or Metastatic Central Nervous System (CNS) Tumor
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2009-03-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 1128
- Registration Number
- NCT00580463
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Lung Cancer Informational Study (LCIS)
Not Applicable
Completed
- Conditions
- CancerEnhanced CareDecision-MakingAdvance Lung CancerStage III Lung CancerStage IV Lung Cancer
- Interventions
- Behavioral: Enhance CareBehavioral: Usual Care
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2009-03-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT00579215
- Locations
- 🇺🇸
University of Virginia- School of Nursing, Charlottesville, Virginia, United States
🇺🇸Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
Early Phase 1
Completed
- Conditions
- Melanoma
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00580060
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
The Queens Library HealthLink Project
Completed
- Conditions
- Multiple Diseases
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 2789
- Registration Number
- NCT00579696
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath